Dovel Technologies subsidiary Medical Science & Computing LLC has been awarded an indefinite delivery, indefinite quantity contract worth a potential of $105 million to support the National Institutes of Health Intramural Research Program.
MSC is to provide a full range of specialized, strategic, technical and operational services for this intramural biomedical and clinical research initiative that covers all institutes, centers and offices within NIH.
This requirement provides critical support to a broad range of NIH activities in process and planned, as well as unanticipated because of new or re-emerging health threats and science advances.
The NIH IRP has a long history of spearheading key scientific breakthroughs, and MSC is proud to be a part of its vital work, said MSC Senior Vice President of Life Sciences Anna Koroleva.
“We are ready to leverage our extensive subject matter expertise in health IT and life sciences to support the acceleration of scientific research and development,” she added.
The scope of the contract includes program management office support; basic, translational and preclinical research; clinical research studies and trials; bioinformatics, bio statistical and technical; operational and management; regulatory and compliance; and other specialized support services.
“We are honored to have this opportunity to continue serving NIH’s mission through intramural biomedical and clinical research,” Dovel CEO Damon Griggs said. “Our ability to blend deep domain expertise and advanced technologies allows our customers to be innovative and improve, protect, and save lives.”